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Summary 
The Norwegian Scientific Committee for Food and Environment (Vitenskapskomiteen for mat 
og miljø, VKM) has, at the request of the Norwegian Food Safety Authority (Mattilsynet; 
NFSA), evaluated the intake of manganese from the diet and 1, 5 or 10 mg manganese per 
day in food supplements. The former maximum limit for manganese in food supplements 
was 5 mg per daily dose.  
Manganese (Mn) is an essential dietary mineral for mammals, and is a component of 
metalloenzymes such as superoxide dismutase, arginase and pyruvate carboxylase. 
Manganese is involved in amino acid-, lipid- and carbohydrate metabolism and in 
proteoglycan synthesis in bone formation. In 2013, the European Food Safety Authority 
(EFSA) suggested 3 mg/day to represent an adequate intake (AI) of manganese because 
data was considered insufficient to set an average requirement (AR). 
Reports of adverse effects resulting from manganese exposure in humans are associated 
primarily with inhalation in occupational settings. Excess oral exposure to manganese, 
especially from contaminated water sources, has been shown to cause permanent 
neurological disorder known as “manganism” which can be irreversible. The amount of 
manganese absorbed is inversely related to the concentration of manganese in the diet. This 
regulation seems to be part of the adaptive changes to the amount of dietary manganese 
intake, which allow the maintenance of manganese homeostasis over a wide range of 
intakes. Manganese is mainly absorbed as Mn(II), and absorption is reported to be below 
10% of ingested manganese. 
The main route of elimination of manganese from the body is via bile to the small intestine, 
while very little is excreted in the urine. Half-life for manganese can vary from 13 to 37 days, 
with a longer half-life in women than in men, but large inter-individual variation exists.  
In Norway, manganese content in drinking water is low, and does not contribute to any 
magnitude of manganese intake. Daily dietary intake of manganese in Norway is not known, 
but it is proposed that manganese intake is adequate in the Scandinavian countries (NNR 
Project Group, 2012). Results from the Swedish Market Basket study, 2015, indicate an 
average daily manganese intake of 4.2 mg per person and day. Calculations based on data 
from Denmark, 2013 and 2015, evaluate mean dietary intake of manganese to 3.9 mg/day 
for adults and up to 6.9 mg/day in the higher intake groups. EFSA report on an observed 
mean intake in EU around 3 mg/day for adults. Main contributor to dietary manganese intake 
is cereals (57%) followed by fruit, vegetables, nuts and coffee/tea.  
Irreversible neurotoxic adverse effects from intakes of manganese close to adequate intakes 
have been reported in humans (SCF, 2000). The Scientific Committee on Food (SCF) could 
not set a no observed adverse effect level (NOAEL), because no relevant dose-response 
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animal studies were found. Consequently SCF did not set a tolerable upper intake level (UL) 
for manganese.  
VKM considers that any dose of manganese as an ingredient in food supplements may be 
associated with increased risk of negative health effects.  
VKM emphasises that the current assessment of maximum limits for manganese in food 
supplements is merely based on published reports concerning upper levels from the IOM 
(2001, USA), SCF (2003, EU), EVM (2003, UK) and NNR (2012, Nordic countries). VKM has 
not conducted any systematic review of the literature for the current opinion, as this was 
outside the scope of the terms of reference from NFSA. 
Key words: VKM, risk assessment, Norwegian Scientific Committee for Food and 
Environment, manganese, food supplement, upper level, exposure. 
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Sammendrag på norsk 
Vitenskapskomiteen for mat og miljø (VKM) har vurdert inntaket av mangan i kosten, og 
dosene 1, 5 eller 10 mg mangan i kosttilskudd på oppdrag fra Mattilsynet. Den tidligere 
maksimumsgrensen for mangan i kosttilskudd var 5 mg/dag. 
Mangan (Mn) er et essensielt mineral for pattedyr, og inngår som komponent i 
metalloenzymer som superoksid dismutase, arginase og pyruvat karboksylase. Mangan 
inngår i metabolismen av aminosyrer, fett og karbohydrater og i proteoglukansyntesen ved 
beindannelse. Ettersom det ikke fantes datagrunnlag for å fastsette såkalt gjennomsnittlig 
behov (Average Requirement=AR), foreslo European Food Safety Authority (EFSA) i 2013 at 
3 mg per dag er å anse som et såkalt adekvat inntak (AI) av mangan. 
De fleste rapportene om negative helseeffekter hos mennesker fra mangan er forbundet 
med eksponering via luftveiene i yrkesrelaterte situasjoner. Høyt oralt inntak av mangan, 
særlig fra kontaminerte drikkevannskilder, har vist å kunne medføre varig (og irreversibel) 
nevrologisk skade kalt «manganisme». 
Mengden mangan som absorberes i kroppen er omvendt relatert til konsentrasjonen av 
mangan i kosten. Denne reguleringen ser ut til å være en del av opprettholdelsen av 
manganhomeostasen selv ved store variasjoner i inntak. Normalt absorberes under 10 % av 
mangan fra kosten, og da hovedsakelig som Mn (II). 
Manganutskilling skjer hovedsakelig via gallen og tynntarmen, og svært lite skilles ut 
gjennom urin. Halveringstiden for mangan varierer fra 13 til 37 dager. Kvinner har generelt 
lengere halveringstid enn menn, men det er store individuelle variasjoner. 
Mangankonsentrasjonene i drikkevann er lave i Norge, og bidrar i liten grad til det totale 
manganinntaket. Daglig inntak av mangan fra kosten i Norge er ikke kjent, men 
manganinntaket fra kosten er vurdert til å dekke behovet i de skandinaviske landene (NNR 
Project Group, 2012). Resultater fra en svensk såkalt «handlekurv-studie» fra 2015 antyder 
et gjennomsnittlig inntak av mangan på 4,2 mg/dag. Beregninger basert på danske data fra 
2013 og 2015, viser et manganinntak på 3,9 mg/dag for voksne og opp til 6,9 mg/dag i 
grupper med høyt manganinntak. 
EFSA rapporterer om et observert gjennomsnittlig inntak i EU på rundt 3 mg/dag. 
Matvaregrupper som bidrar mest til manganinntaket er korn og kornprodukter (57 %) 
etterfulgt av frukt, grønnsaker, nøtter og kaffe/te. 
Det er rapportert om irreversible nevrotoksiske bivirkninger fra inntak av mangan nært såkalt 
adekvat inntak (AI) hos mennesker (SCF, 2000). Scientific Committee on Food (SCF) kunne 
ikke angi en NOAEL – det vil si et inntaksnivå der man ikke har sett noen skadelige effekter, 
fordi ingen relevante dyrestudier ble funnet. Mangel på muligheten for å fastsette en NOAEL 
og det at man har sett nevrologiske effekter på mennesker ved lave inntak resulterte i at SCF 
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ikke har fastsatt et tolerabelt øvre inntaksnivå (UL) for mangan. VKM konkluderer derfor med 
at alle mangandosene i kosttilskudd vil kunne medføre økt risiko for negative helseeffekter.  
VKM presiserer at denne vurderingen av maksimumsgrenser for mangan i kosttilskudd er 
basert på publiserte rapporter om øvre inntaksnivåer fra IOM (2000, USA), SCF (2003, EU), 
EVM (2003, Storbritannia) og NNR (2012, de nordiske landene). Ettersom mandatet i 
bestillingen fra Mattilsynet var å vurdere inntaket av mangan basert på allerede eksisterende 
rapporter, har VKM for denne uttalelsen ikke gjennomført et eget systematisk litteratursøk 
for å vurdere det samlede kunnskapsgrunnlaget. 
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Abbreviations and/or glossary 
Abbreviations 
AI – adequate intake 
AR – average requirement 
ATSDR – Agency for Toxic Substances and Disease Registry, USA 
BMI – body mass index 
bw – body weight 
CI – confidence interval 
Da – Dalton 
DRI – dietary reference intake 
DRV – dietary reference value 
DTU – Danish Technical University 
EAR – estimated average requirement 
EFSA – European Food Safety Authority 
EVM – Expert group on Vitamins and Minerals of the Food Standard Agency, UK 
IOM – Institute of Medicine, USA 
LOAEL – lowest observed adverse effect level 
MRL – minimal risk level 
NFSA – Norwegian Food Safety Authority [Norw.: Mattilsynet] 
NNR – Nordic Nutrition Recommendations 
NOAEL – no observed adverse effect level 
PRI – population reference intake 
RDA – recommended dietary allowances 
RI – recommended intake 
SCF – Scientific Committee on Food 
SUL – safe upper intake level 
UF – uncertainty factor 
UL – tolerable upper intake level 
VKM – Norwegian Scientific Committee for Food and Environment [Norw.: 
Vitenskapskomiteen for mat og miljø] 
Glossary 
P5, P25, P50, P75 or P95-exposure is the calculated exposure at the 5, 25, 50, 75 or 95-
percentile. 
Percentile is a term for visualising the low, medium and high occurrences of a 
measurement by splitting the whole distribution into one hundred equal parts. A percentile is 
a statistical measure indicating the value below which a given percentage of the observations 
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fall. E.g. the 95-percentile is the value (or score) below which 95 percent of the observations 
are found. 
EFSA - Dietary Reference Values (DRVs) (EFSA, 2010) 
Average Requirement (AR) is the level of intake of a defined group of individuals 
estimated to satisfy the physiological requirement of metabolic demand, as defined by a the 
specific criterion for adequacy for the nutrient, in half of the heathy individuals in a life stage 
or sex group, on the assumption that the supply of other nutrients and energy is adequate. 
If an AR cannot be determined than an Adequate Intake is used. 
Adequate Intake (AI) is defined as the average (median) daily level of intake based on 
observed, or experimentally determined approximations or estimates of a nutrient intake, by 
a group (or groups) of apparently healthy people, and therefore assumed to be adequate. 
The practical implication of an AI is similar to that of a population reference intake, i.e. to 
describe the level of intake that is considered adequate for health reasons. The 
terminological distinction relates to the different ways in which these values are derived and 
to the resultant difference in the "firmness" of the value.  
Population Reference Intake (PRI) is derived from AR of a defined group of individuals 
in an attempt to take into account the variation of requirements between individuals.  
 
 
Figure 1: Population reference intake (PRI and average requirements (AR), if the requirement has a 
normal distribution and the inter-individual variation is known (EFSA, 2010). 
Lower Threshold Intake (LTI) is the lowest estimate of requirement from the normal 
distribution curve, and is generally calculated on the basis of the AR minus twice its SD. This 
will meet the requirement of only 2.5% of the individuals in the population.  
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Tolerable Upper intake Level (UL) is the maximum level of total chronic daily intake of a 
nutrient (from all sources) judged to be unlikely to pose a risk of adverse health effects to 
humans.  
 
Figure 2: Relationship between individual intake and risk of adverse effects due to insufficient or 
excessive intake. 
IOM - Dietary Reference Intakes (DRIs) (IOM, 2000) 
Estimated Average Requirement (EAR) is a nutrient intake value that is estimated to 
meet the requirement of half the healthy individuals in a life stage and gender group.  
Recommended Dietary Allowances (RDA) is the dietary intake level that is sufficient to 
meet the nutrient requirement of nearly all (97 to 98 percent) healthy individuals in a 
particular life stage and gender group. RDA = EAR + 2 SDEAR or if insufficient data to 
calculate SD a factor of 1.2 is used to calculate RDA; RDA = 1.2*EAR. 
Adequate Intake (AI) is the recommended intake value based on observed or 
experimentally determined approximations or estimates of nutrient intake by a group (or 
groups) of healthy people that are assumed to be adequate – used when an RDA cannot be 
determined. 
Tolerable Upper Intake Level (UL) is the highest level of nutrient intake that is likely to 
pose no risk of adverse health effects for almost all individuals in the general population.  
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Figure 3: Dietary reference intakes. 
NNR -Recommended Intake (NNR Project Group, 2012) 
Average Requirement (AR) is defined as the lowest long-term intake level of a nutrient 
that will maintain a defined level of nutritional status in an individual i.e. the level of a 
nutrient that is sufficient to cover the requirement for half of a defined group of individuals 
provided that there is a normal distribution of the requirement.  
ARNNR = EARIOM = AREFSA 
Recommended Intake (RI) is defined as the amount of a nutrient that meets the known 
requirement and maintains good nutritional status among practically all healthy individuals in 
a particular life stage or gender group. RI= AR + 2SDAR.  
RINNR = RDAIOM = PRIEFSA 
Upper Intake Level (UL) is defined as the maximum level of long-term (months or years) 
daily nutrient intake that is unlikely to pose a risk of adverse health effects in humans.  
ULNNR =ULIOM = ULEFSA 
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Figure 4: Derivation of Upper Intake Level (UL)  
UF: Uncertainty factor 
Expert group on vitamins and minerals (EVM), UK (EVM, 2003) 
Safe Upper Intake Level (SUL): EVM used SUL instead of UL and defined SUL as the 
determination of doses of vitamins and minerals that potentially susceptible individuals could 
take daily on a life-long basis, without medical supervision in reasonable safety. The setting 
of these levels provided a framework within which the consumer could make an informed 
decision about intake, having confidence that harm should not ensue. The levels so set will 
therefore tend to be conservative. 
Guidance Level (GL): For vitamins and minerals where a SUL could not be established due 
to insufficient data, EVM provided GL as an approximate indication of levels that would not 
be expected to cause adverse effects. As with SULs, the GLs are intended to represent the 
doses of vitamins and minerals that susceptible individuals could take daily on a life-long 
basis, without medical supervision. The EVM emphasised, however, that GLs should not be 
used as SULs, as they have been derived from limited data and are less secure than SULs.   
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° 
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Background as provided by the 
Norwegian Food Safety Authority 
Directive 2002/46/EC on food supplements was implemented into Norwegian law in 2004 in 
Regulation 20 May 2004 No. 755 on food supplements. Pursuant to Directive 2002/46/EC, 
common maximum and minimum levels of vitamins and minerals in food supplements shall 
be set in the EU. The European Commission started to establish common limits in 2006, but 
the work was temporarily put on standstill in 2009. The time frame for the further work is 
not known.  
National maximum limits for vitamins and minerals were established in the former vitamin 
and mineral supplements regulation from 1986 and were continued in the 2004 regulation.  
The national maximum and minimum limits in the food supplement regulation were 
established a long time before the food supplement directive was adopted, and the limits 
were consequently not established in accordance with the criteria for limits set in the food 
supplement directive. Maximum limits for vitamins and minerals which were not already 
revised according to the criteria in article 5 in the food supplement directive, were therefore 
repealed from 30 May 2017.  
Maximum limits for levels of vitamins and minerals in food supplements shall be set on basis 
of the following criteria, pursuant to article 5 in Directive 2002/46/EC:  
• Upper safe levels of vitamins and minerals established by scientific risk assessment 
based on generally accepted scientific data, taking into account, as appropriate, the 
varying degrees of sensitivity of different consumer groups  
• Intake of vitamins and minerals from other dietary sources  
When the maximum levels are set, due account should also be taken of reference intakes of 
vitamins and minerals for the population.  
Pending establishment of common maximums limits in the EU, the Norwegian Food Safety 
Authority is evaluating the national maximum limits for vitamins and minerals in food 
supplements.  
Norwegian authorities will as soon as possible, when it exists a scientific basis, and pending 
establishment of common maximums limits in the EU, establish new national maximum limits 
for those vitamins and minerals where limits were repealed 30 May 2017.  
Assessment of manganese  
The Norwegian Food Safety Authority will consider establishing a new national maximum 
limit for manganese in the food supplement regulation.  
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The former maximum limit for manganese of 5 mg per daily dose was repealed from 30 May 
2017. The minimum limit and permitted manganese substances that may be used in the 
manufacture of food supplements, are listed in annex 1 and annex 2 in the food supplement 
regulation.  
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Terms of reference as provided by the 
Norwegian Food Safety Authority 
The Norwegian Food Safety Authority (NFSA, Mattilsynet) requests the Norwegian Scientific 
Committee for Food and Environment (VKM) to assess the intake of manganese from the 
diet, in all age groups in the population above 1 year.  
As there is no data on manganese in the Norwegian food composition data base (KBS), VKM 
is requested to evaluate if other relevant intake data can be used - included Danish intake 
data estimated by the National Food Institute in Denmark (DTU). 
VKM is also requested to evaluate the consequences of establishing a maximum limit for 
manganese in food supplements of 1, 5 or 10 mg per daily dose, and to evaluate these 
scenarios against existing tolerable upper intake levels. 
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Assessment manganese 
1 Introduction 
Manganese (Mn) has an atomic mass of 54.9 Dalton (Da) and exists in a number of oxidation 
states ranging from -3 to +7. Mn(II) and Mn(III) are the prominent forms in biological 
systems (SCF, 2000). Manganese is an essential dietary mineral for mammals, and is a 
component of metalloenzymes such as superoxide dismutase, arginase and pyruvate 
carboxylase. Manganese is involved in amino acid-, lipid- and carbohydrate metabolism and 
in proteoglycan synthesis in bone formation (IOM, 2001; SCF, 1993). 
Manganese deficient animals demonstrate impaired growth, skeletal abnormalities, 
reproductive deficits, ataxia of the newborn and defects in lipid and carbohydrate 
metabolism. Evidence of manganese deficiency in humans is poor and no specific syndrome 
has been described. A fleeting dermatitis, miliaria crystalline, developed in five out of seven 
male subjects on a purified diet with 0.11 mg/day of manganese for 39 days (Friedman et 
al., 1987 cited in EFSA, 2013). 
Reported adverse effects of excess manganese in humans are primarily results of 
manganese inhalation in occupational settings. Oral exposure to manganese, especially from 
contaminated water sources, may also cause adverse health effects similar to those observed 
from inhalation exposure. The symptoms of manganese toxicity include tremors, difficulty 
walking, and facial muscle spasms, and may appear slowly over months and years. The final 
outcome can be a permanent neurological disorder known as manganism (ATSDR, 2012).  
Estimated dietary daily intake of manganese in Norway is not known. Based on other 
European data, the main contributor to dietary manganese intake is cereals (57%) followed 
by fruit, vegetables, nuts and tea (EFSA, 2013).  
The amount of manganese absorbed is influenced by the concentration of manganese in the 
diet. Low dietary manganese intake results in increased manganese absorption relative to 
intake (Finley, 1999; Finley et al., 2003 both cited in EFSA, 2013). Regulation at the level of 
absorption seems to be part of the adaptive changes to the amount of dietary manganese 
intake, which allow the maintenance of manganese homeostasis over a wide range of 
intakes.  
Manganese is mainly absorbed as Mn(II), and intestinal absorption of manganese is reported 
to be below 10% (EFSA, 2013). Absorption of radioisotope labelled manganese from 
vegetable sources (lettuce, spinach, wheat, sunflower seeds) was shown to range from 1.7% 
to 5.2% compared with 7.7 to 10.2% absorption from a manganese chloride solution with a 
comparable manganese content (Johnson et al., 1991 cited in EFSA, 2013). Absorption has 
been suggested to take place through active transport mechanisms and passive diffusion. 
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High intakes of calcium, phosphorus and phytates have been reported to impair manganese 
absorption (ATSDR, 2012; IOM, 2001; SCF, 1993).  
Absorbed manganese is transported to the liver and is further distributed to other tissues 
bound to transferrin, alpha2-macroglobulin and albumin. The concentration of manganese in 
blood of healthy adults ranges from 4-15 µg/L and with a higher concentration measured 
during pregnancy (15-20 µg/L). An even higher concentration is found in cord blood (30-
40 µg/L) (EFSA, 2013). In plasma, manganese Mn(II) tends to be oxidised to Mn(III) and it 
is in this state manganese is found in several enzymes.  
The main route of elimination of manganese from the body is via bile to the small intestine, 
while very little is excreted in the urine (ATSDR, 2012). Half-life for manganese can vary 
from 13 to 37 days, with a longer half-life in women than in men. However, large inter-
individual variations exist.  
  
  
VKM Report 2018: 02  19 
2 Recommendations and tolerable 
upper intake levels 
2.1 Recommendations 
There are no Norwegian recommendations for intake of manganese. The Nordic Nutrition 
Recommendations (2012) concluded that no recommendations could be given for 
manganese due to lack of sufficient evidence (NNR Project Group, 2012). 
The European Food Safety Authority (EFSA) concluded that data is insufficient for deriving 
Average Requirements (ARs) or Population Reference Intakes (PRIs) for manganese. EFSA 
proposed an Adequate Intake (AI) at 3 mg/day for adults based on observed mean intake 
from a mixed diet in the EU as stated in Dietary Reference Values (DRVs) for manganese 
(EFSA, 2013). AI at 3 mg/day included pregnant and lactating women. AIs for children were 
calculated with use of isometric scaling. These AIs are presented in Table 2.1-1. 
Table 2.1-1 Adequate Intakes for manganese from EFSA (2013).  
Age, both sexes mg/day(a) 
1-3 years 0.5 
4-6 years 1.0 
7-10 years 1.5 
11-14 years 2.0 
15-17 years 3.0 
≥18 years* 3.0 
(a) Calculated using isometric scaling: AIchild = AIadult x (body weight of child/body weight of adult), 
where weight of adult is the average of the median body weight of 18- to 79-year-old men and 
women based on measured body heights of 16 500 men and 19 969 women in 13 EU Member States 
and assuming a body mass index (BMI) of 22 kg/m2 (see Appendix 11 in EFSA (2013)). Rounded to 
the nearest 0.5. 
*Including pregnancy and lactation. 
The U.S. Institute of Medicine (IOM) 2001 concluded that for manganese, there was not 
sufficient information to set Estimated Average Requirement (EAR) and Recommended 
Dietary Allowances (RDA), so requirements are described as estimates for Adequate Intakes 
(AIs) for the different age groups. The U.S. AIs for manganese for women and men from 
ages 19 and up are 1.8 and 2.3 mg/day, respectively. AI during pregnancy is 2.0 mg/day 
based on extrapolation with a weight gain of 16 kg, and for lactating women 2.6 mg/day 
based on median intake during lactation. For children aged 1-18 years, the AI increases with 
age from 1.2 to 2.2 mg/day for males, to 1.6 mg/day for females, all derived from calculated 
intakes.  
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Table 2.1-2 Adequate Intakes for manganese from IOM (2001).  
Age, both sexes mg/day 
male 
mg/day 
female 
1-3 years 1.2 1.2 
4-8 years 1.5 1.5 
9-13 years 1.9 1.6 
14-18 years 2.2 1.6 
>18 years 2.3 1.8 
Pregnancy   2.0 
Lactation  2.6 
2.2 Tolerable upper intake levels 
 Scientific Committee on Food (SCF, 2000), EU 
In 2000, the Scientific Committee on Food (SCF) concluded that oral intakes of manganese 
can cause adverse effects, both in humans and experimental animals. The critical organ is 
the central nervous system. Most studies on the neurotoxic effects in humans are from 
reports with oral intake of manganese through drinking water. Assuming a consumption of 2 
litres of drinking water per day, cohorts showing neurotoxic effects were exposed to 28 mg 
Mn/day (Kawamura et al., 1941 cited in SCF, 2000), 0.16 – 0.5 and 3.6 – 4.4 mg Mn/day 
(Kondakis et al., 1989) and 0.48 – 0.69 mg Mn/day (He at al., 1994 cited in SCF, 2000) plus 
the contribution from food. In another study no adverse effects were found with intake from 
drinking water between 0.6 - 4.3 mg Mn/day plus contribution from food (Vieregge et al., 
1995). However, the limitations of these studies, which also includes the uncertainty of 
contribution from food, make firm conclusions difficult. Similarly, SCF concluded that results 
from dose-response animal studies of adverse effects of Mn were too uncertain to set a no 
observed adverse effect level (NOAEL) for critical endpoints, mostly because all studies used 
high doses which consistently resulted in neurotoxic effects. The lowest dose affecting the 
central nervous system was found in a study with growing male rats, in which 50 µg 
MnCl2,4H2O/rat, initially equivalent to 0.28 mg Mn/kg bw, were given by stomach tube daily 
for 15 to 60 days (Chandra and Shukla, 1978). Furthermore, concerns were expressed of a 
potentially higher susceptibility of oral exposure to manganese among neonates and children 
who retain a much higher percentage of ingested manganese compared to adults.  
SCF (2000) concluded that the margin between oral effect levels in humans and the 
estimated intake from food was very low. Given the findings on neurotoxicity and the 
potentially higher susceptibility of some subgroups in the general population, oral exposure 
to manganese beyond the levels normally present in food and beverages could represent a 
risk of adverse health effects and therefore SCF (2000) did not set a tolerable upper intake 
level (UL) for manganese.  
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 Institute of Medicine (IOM, 2001), USA 
In setting an UL for manganese, the IOM used elevated blood manganese concentration and 
neurotoxicity as the critical adverse effects (IOM, 2001). Animal studies were considered, but 
were evaluated to have poor quality and a NOAEL was not set.  
A NOAEL of 11 mg/day of manganese from food was identified based on the data presented 
by Greger (1999) cited in IOM (2001). Greger (1999) reviewed information indicating that 
people eating Western-type and vegetarian diets may have intakes as high as 10.9 mg/day 
of manganese. Schroeder and coworkers (1966) reported that a manganese-rich vegetarian 
diet could contain 13 to 20 mg/day of manganese. Because no adverse effects due to 
manganese intake had been noted, at least not in people consuming Western diets, 11 
mg/day was set as a reasonable NOAEL from food. A lowest observed adverse effect level 
(LOAEL) was identified on the basis of 47 women who were supplemented for 124 days with 
15 mg/Mn/day Davis and Greger (1992) cited in IOM (2001). At this dose, there were 
significant increases in serum manganese concentrations after 25 days of supplementation 
and in lymphocyte manganese-dependent superoxide dismutase activity after 90 days of 
supplementation. 
The UL for manganese for adults was set at 11 mg/day, and UL for children and adolescents 
were extrapolated from those established for adults based on relative body weight. The 
uncertainty factor (UF) was set to 1, because intake data was based on a human study. 
Table 2.2.2-1 Tolerable upper intake levels for manganese in different age groups suggested by the 
IOM (2001).  
Age (years) UL mg/day  
1-3 2 
4-8 3 
9-13 6 
14-18 9 
19 and older 11 
 Expert Group on Vitamins and Minerals (EVM, 2003), UK 
The Expert Group on Vitamins and Minerals (EVM) has given a guidance level for total intake 
of manganese including a supplemental intake of 4 mg manganese per day. This guidance 
level was based on two epidemiological studies. EVM concluded that data were insufficient to 
establish a safe upper level (SUL) for manganese. 
Kondakis et al., 1989 
This was a retrospective study of three cohorts exposed to drinking water containing 0.0036-
0.015, 0.08-0.25 or 1.8-2.3 mg/L manganese (Kondakis et al., 1989). The subjects were all 
aged over 50 years and had been exposed to manganese for more than 10 years. Assuming 
2L/day water consumption, intakes for the three groups could be estimated to be 0.0072-
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0.03, 0.16-0.5 and 3.6-4.6 mg manganese per day from drinking water in addition to dietary 
manganese. There was no difference in blood manganese levels in subjects from the three 
areas, but hair manganese was higher in subjects in the area with the highest level of 
manganese in drinking water. It has been noted (US Health and Human Services) that hair 
manganese is a useful measure of exposed versus unexposed populations but that it is of 
limited use in assessing individual exposure. Neurological signs and symptoms were elevated 
in subjects from the highest manganese area. The symptoms ranged from depression, 
fatigue and hallucinations to tremor and impaired reflexes. The authors attributed this 
finding to the age of the subjects, making them more susceptible to neuronal loss with 
ageing. The study was limited by inconsistent evidence of significant excess exposure and 
the subjective ascertainment of clinical effects. 
Vieregge et al., 1995 
This was a retrospective study based on two cohorts in which participants were exposed to 
water containing <0.05 mg/L or >0.3 mg/L (range 0.3-2.16 mg/L) manganese. The subjects 
in the two groups were aged 41-84 (mean 57.5) years and 41-86 (mean 56.9) years. Long 
duration of exposure (10-40 years) to manganese had taken place. Assuming 2 L/day water 
consumption, manganese intakes of 0.1 and 4.3 mg from water could be estimated. No 
significant differences in blood manganese levels or neurological scores were found between 
the two groups. The authors noted the conflict with the findings of Kondakis et al. (1989), 
which they attributed to the higher age of the participants in that study. The study of 
(Vieregge et al., 1995) was also limited by the lack of data on dietary manganese exposure. 
Animal data indicate similar neurotoxic effects and additional adverse effects on haematology 
and reproductive parameters. 
For guidance purposes, it was reasoned that in the general population, a supplemental 
intake of up to 4 mg manganese/day, in addition to the dietary manganese, would be 
unlikely to induce adverse effects (equivalent to 0.07 mg/kg bw for a 60 kg adult) based on 
the NOAEL from the Vieregge study. No uncertainty factor was stated to be required as the 
NOAEL is based on a large epidemiological study. Using the NOAEL from the Kondakis study, 
it was assumed that up to 0.5 mg/day of manganese (equivalent to 0.008 mg/kg bw for a 
60 kg adult) in addition to the diet would not result in adverse effects in older people. 
Assuming a dietary intake of 8.2 mg, acceptable total manganese intakes were estimated to 
be 12.2 mg/day in the general population (equivalent to 0.2 mg/kg bw in a 60 kg adult) and 
8.7 mg/day (equivalent to 0.15 mg/kg bw in a 60 kg adult) for older people. 
It was stated that some population groups may be exposed to higher levels of manganese as 
a result of tea consumption, making tea the largest contributor to manganese intake in the 
UK. 
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 Nordic Nutrition Recommendations (NNR, 2012) 
NNR Project Group (2012) has not set an UL for manganese with reference to the SCF 
finding data too uncertain to set an UL, and to EVM reporting data insufficient to set a SUL 
for manganese. 
 Summary upper intake levels 
Table 2.2.5-1 summarises the evaluation of upper intake levels from the authorities 
mentioned above. An UL was set by the IOM based on intake data from food, while food 
supplement data was not used. 
Table 2.2.5-1 Overview of upper intake levels in adults set by various authorities.  
  
Authority Upper level, 
mg/day 
Based on NOAEL 
mg/day 
LOAEL 
mg/day 
UF 
IOM, 2001 11 Human studies –
intake from 
Western diet 
without any 
neurotoxic effects 
11 15 1 
SCF, 2000 None     
EVM, 2003 4, from supplements 
only as a guidance level 
(GL) and assuming 8.2 
from diet  
Human studies on 
drinking water 
4 suppl.  1 
NNR, 2012 None (ref SCF and EVM)     
  
VKM Report 2018: 02  24 
3 Intakes of manganese 
3.1 Dietary intake of manganese in Norway 
There are no data on habitual intake of manganese in the Norwegian population, because no 
available data exists for manganese in the Norwegian food composition table. Neither has 
there been performed evaluations with Duplicate studies, Market Baskets methods or Total 
Diet methods. 
Water can be an important manganese source, but information from Water Works Norway 
shows low concentrations in drinking water in Norway (personal communication/FHI). Mean 
intake of manganese through water will be between 0.02 and 0.34 mg/day if intake is 
around 2 litre water per day. 
Table 3.1-1 Concentration of manganese in drinking water in different regions in Norway. 
Regions Mean 
mg/L 
Max 
mg/L 
Min 
mg/L 
Norway- East 0.02 0.05 0.01 
Norway – South 0.01 0.01 0.00 
Norway- West 0.01 0.04 0.01 
Norway- Middle 0.02 0.02 0.01 
Norway - North 0.01 0.17 0.01 
3.2 Dietary intake of manganese in Europe 
 Sweden 
Estimated daily intake of manganese analysed in a Market Basket study in 2015, was 4.2 mg 
per person and day (Livsmedelsverket, 2017), which was close to the results from a Market 
Basket study in 2010 (4.0 mg). Main contributor to estimated manganese intake was cereals 
(57%). 
 Denmark 
In Denmark, the Danish Technical University (DTU) has evaluated the daily intake of 
manganese in 100 men by collecting duplicate portions of their regular diets for 48 hours 
which showed a manganese intake of 3.9 mg/day (Bro et al., 1990).  
DTU has performed new dietary intake calculations of manganese based on energy intake in 
different age groups from Danskenes kostvaner 2013 and 2015. Danskenes kostvaner is a 
nationally representative survey of diet and physical activity in the Danish population aged 4-
75 years and was carried out in 2011-2013 (DANSDA) (DTU, 2015). Diet was assessed 
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through a 4-day food record. Manganese was not part of the standard battery of minerals 
calculated. 
Through communication with the Danish Veterinary and Food Administration, NFSA has 
obtained data on dietary manganese. 
Table 3.2.2-1 Median and 95-percentiles of intake of manganese from the diet in various age groups 
in the Danish population, estimated by the DTU. 
Age  50 percentile-
intake 
(mg/day) 
95 percentile-
intake 
(mg/day) 
1-3  2.1  4.3  
4-6  3.2 5.4  
7-10  3.4 6.7  
11-14  3.0  7.2  
15-17  2.8  7.2  
Women 25-34  3.9 6.9  
Women 55-75  3.9  6.9  
Women 65-75  3.7  6.9  
Accordingly, it is suggested that manganese intake is adequate in the Scandinavian countries 
(NNR Project Group, 2012). 
 Other EU countries 
Manganese intake among Finnish children 3-18 years was in the range of 3-7 mg/day 
calculated from food consumption data and food contents (Bro et al., 1990) 
In EFSA (2013) on DRVs for manganese, national dietary surveys among children as well as 
among adults in EU countries are listed. Furthermore, duplicate studies, total diet studies 
and market basket studies are listed. Main food contributors are cereal-based products, 
vegetables, fruits and beverages (coffee, tea and alcoholic beverages).  
Table.3.2.3-1 Mean (SD) intakes of manganese in different age groups reported in EU calculated 
from different dietary surveys. 
Age group Mean (SD) (mg/day) 
(country) 
Males 
Mean (SD) (mg/day) 
(country) 
Females 
1-3 years No data No data 
4-6 years No data No data 
7-9 years 1.7 (IRL) - 3.0 (A) 1.6 (IRL) - 2.9 (A) 
10-14 years 2.3 (F) - 3.2 (A) 2.0 (F) - 2.8 (A) 
15-17 years 2.4 (F) - 3.9 (SLO) 2.0 (F) - 2.8 (SLO) 
Adults 3.1 (F) - 3.6 (IRL) 2.7 (F) – 3.3 (IRL) 
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Age group Mean (SD) (mg/day) 
(country) 
Males 
Mean (SD) (mg/day) 
(country) 
Females 
Adults  
> 60 years 
2.1 (H) - 4.3 (A) 2.9 (H) - 4.4 (A) 
IRL=Ireland, A=Austria, F=France, H=Hungary, SLO=Slovakia. 
Table.3.2.3-2 Mean habitual manganese intakes (mg/kg bw per day) in different age groups 
reported in EU as evaluated by Duplicate studies, Total Diet studies or Market Basket studies.  
Age group Duplicate/total diet/ 
market basket studies 
Males 
Duplicate/total diet/ 
market basket studies 
Females 
1.5 -4.5 years (UK)  
mean mg/kg bw per day 0.168 (P97.5=0.305) 0.168 (P97.5=0.305) 
4-18 years (UK)  
mean mg/kg bw per day 0.106 (P97.5= 0.201) 0.106 (P97.5= 0.201) 
3-17 years (F) 
 mean mg/day 1.5 (P97.5=2.6) 1.5 (P97.5=2.6) 
30-34 years (DK)  
mean mg/day (SD) 4.5 (2.2)  
24-35 years -pregnant (SF) 
mean mg/day   4.45-5.49 
18-79 years (F)  
mean mg/day 2.16 (P95=3.55) 2.16 (P95=3.55) 
20-69 years (D)  
mean mg/day 2.7-3.4 2.1-2.8 
Adults (I) 
mean mg/day 1.38 1.38 
18-74 years (NL)  
mean mg/day 3.3 3.3 
Adults and children (UK) 
mean mg/day  5.24 5.24 
UK=United Kingdom, F=France, DK=Denmark, D=Deutschland, NL=the Netherlands, SF=Finland, 
I=Italy.  
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4 Assessment of the suggested 
maximum limits for manganese in 
dietary supplements  
VKM supports the decision of SCF not setting an UL for manganese. SCF (2000) concluded 
that the margin between oral effect levels in humans and the estimated intake from food 
was very low. Arguments used in the decision of SCF (2000) were that given the findings on 
neurotoxicity and the potentially higher susceptibility of some subgroups in the general 
population, oral exposure to manganese beyond the levels normally present in food and 
beverages could represent a risk of adverse health effects. In a recent extensive report on 
environmental exposure to manganese by (ATSDR, 2012), it was concluded that no oral 
minimal risk levels could be derived for acute-, intermediate- or chronic-duration exposure to 
excess inorganic manganese because of inconsistencies in the dose-response relationship 
across studies. Furthermore, in the ATSDR report it is expressed concern about lack of 
information regarding all intakes of manganese (e.g. dietary intakes plus supplementation 
doses). 
The mean dietary intakes of adults of 3.9 mg/day (Denmark) and 4 mg/day (Sweden) are 
within an adequate intake (AI) as suggested by EFSA (2013) (3 mg/day for adults). In (NNR 
Project Group, 2012) it is suggested that manganese intake in the Scandinavian countries is 
adequate. According to data obtained from DTU in Denmark, intake in the 95 percentiles in 
various age groups ranging from 1 to 75 years was 4.3 – 7.2 mg/day. Adult men were not 
included in these figures. 
Irreversible neurotoxic adverse effects from intakes of manganese close to adequate intakes 
have been reported in humans. Furthermore, manganese intakes are assumed to be 
adequate and subsequently there is no scientific rationale for including manganese in food 
supplements. VKM considers that any dose of manganese as an ingredient in food 
supplements may be associated with increased risk of negative health effects. 
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5 Uncertainties 
For the determinations of the ULs for manganese, SCF, IOM and EVM have not reached the 
same conclusions, indicating uncertainty regarding establishment of these ULs both for 
adults, and even more for children and adolescents. Long-term clinical studies are requested 
by all these scientific bodies to ascertain ULs of scientific value. 
In Norway there are no data on dietary intake of manganese in the population and intake 
data are collected from Denmark and Sweden, as well as from other European countries. 
Uncertainties regarding methods for collecting intake data is also noticeable. 
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6 Answers to the terms of reference 
The Norwegian Food Safety Authority (NFSA, Mattilsynet) has requested the Norwegian 
Scientific Committee for Food and Environment (VKM) to assess the intake of manganese 
from the diet, including fortified products, in all age groups in the population above 1 year. 
As there is no data on manganese in the Norwegian food composition data base (KBS), VKM 
is requested to evaluate if other relevant intake data can be used - included Danish intake 
data estimated by the National Food Institute in Denmark (DTU). 
VKM is also requested to evaluate the consequences of establishing a maximum limit for 
manganese in food supplements of 1, 5 or 10 mg per daily dose, and to evaluate these 
scenarios against existing tolerable upper intake levels. 
Because no dietary intake data for manganese exists for Norway, VKM has gathered dietary 
information from Denmark and Sweden. These data suggest a mean dietary intake of 3.9 
mg/day in Denmark and 4 mg/day of manganese in Sweden. In (NNR Project Group, 2012) 
manganese intake is evaluated to be adequate in the Scandinavian countries.  
Irreversible neurotoxic adverse effects from intakes of manganese close to adequate intakes 
have been reported. Furthermore, manganese intakes are assumed to be adequate and 
subsequently there is no scientific rationale for including manganese in food supplements. 
VKM considers that any dose of manganese as an ingredient in food supplements may be 
associated with increased risk of negative health effects. 
VKM emphasises that the current assessment of maximum limits for manganese in food 
supplements is merely based on published reports concerning upper levels from the IOM 
(2001, USA), SCF (2003, EU), EVM (2003, UK) and NNR (2012, Nordic countries). VKM has 
not conducted any systematic review of the literature for the current opinion, as this was 
outside the scope of the terms of reference from NFSA. 
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7 Data gaps 
EFSA has not set an UL for manganese. Furthermore, no Norwegian intake data for 
manganese exits. 
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